A landmark study exploring the cardiovascular safety and benefits of Semaglutide in a large cohort of patients with type 2 diabetes
These facts led to the search for and design of GST inhibitors, including their synthetic analogues and glutathione conjugates, however, most of the existing inhibitors are either too toxic to be used in vivo or are effective only in vitro [14, 15]
The central leptin gene therapy has also been effective to insulin-deficient diabetes in obesity animal models such as ob/ob mise, diet-induced obese mice, and insulin-deficient type 1 diabetes mice (Kojima et al., 2009), and in patients with inactivating mutations in the leptin gene (Farooqi et al., Herein, we review the role of leptin in regulating feeding behavior and glucose metabolism and also the therapeutic potential of leptin in obesity and diabetes mellitus
10.3109/08923970903279991 65 KimS.-H.JunC.-D.SukK.ChoiB.-J.LimH.ParkS.et al (2006)
Annals of Internal Medicine DOI:10.7326/ANNALS-25-00860 Abstract Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy: A Target Trial Emulation Background: There are few data evaluating the association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and nonarteritic anterior ischemic optic neuropathy (NAION), which constitutes approximately 75% of ischemic optic neuropathy (ION) cases in adults
Retatrutide Peptide Retatrutide is an investigational peptide
